Galway Bay fm newsroom - A Galway city headquartered medical technology company has received €3.6 million in grant funding which will help it commercialise a device to treat a colorectal condition.
Signum Surgical, which is based at New Docks in the city, has received €2.3 million from the EU Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund.
This therapy for patients with a common colorectal disease involves a minimally invasive BioHealx technology designed to reduce surgical trauma, healing time, and total cost of care.
Advertisement
